Iradimed (IRMD) Shareholder's Equity Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.39% |
| Dec 31, 2025 | 8.98% |
| Sep 30, 2025 | 17.88% |
| Jun 30, 2025 | 18.36% |
| Mar 31, 2025 | 18.30% |
| Dec 31, 2024 | 21.56% |
| Sep 30, 2024 | 11.89% |
| Jun 30, 2024 | 15.47% |
| Mar 31, 2024 | 18.31% |
| Dec 31, 2023 | -3.06% |
| Sep 30, 2023 | 6.87% |
| Jun 30, 2023 | 4.70% |
| Mar 31, 2023 | 2.86% |
| Dec 31, 2022 | 2.08% |
| Sep 30, 2022 | 2.77% |
| Jun 30, 2022 | 1.54% |
| Mar 31, 2022 | -0.84% |
| Dec 31, 2021 | 17.58% |
| Sep 30, 2021 | 11.82% |
| Jun 30, 2021 | 11.20% |
| Mar 31, 2021 | 8.64% |
| Dec 31, 2020 | 10.55% |
| Sep 30, 2020 | 17.27% |
| Jun 30, 2020 | 23.79% |
| Mar 31, 2020 | 30.05% |
| Dec 31, 2019 | 32.37% |
| Sep 30, 2019 | 29.13% |
| Jun 30, 2019 | 108.97% |
| Mar 31, 2019 | 4,203,862.05% |
| Dec 31, 2018 | 27.38% |
| Sep 30, 2018 | 24.74% |
| Jun 30, 2018 | -27.91% |
| Mar 31, 2018 | -100.00% |
| Dec 31, 2017 | 3.27% |
| Sep 30, 2017 | 4.89% |
| Jun 30, 2017 | 9.93% |
| Mar 31, 2017 | 9.51% |
| Dec 31, 2016 | -0.14% |
| Sep 30, 2016 | 9.00% |
| Jun 30, 2016 | 13.48% |
| Mar 31, 2016 | 27.34% |
| Dec 31, 2015 | 52.86% |
| Sep 30, 2015 | 39.52% |
| Jun 30, 2015 | 243.63% |
| Dec 31, 2014 | 285.24% |